pargyline has been researched along with Obesity in 3 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpéné, C | 1 |
| Iffiú-Soltesz, Z | 1 |
| Bour, S | 1 |
| Prévot, D | 1 |
| Valet, P | 1 |
| Dawson, R | 1 |
| Callahan, MF | 1 |
| Annau, Z | 1 |
| Hellman, B | 1 |
| Lernmark, A | 1 |
| Sehlin, J | 1 |
| Täljedal, IB | 1 |
3 other studies available for pargyline and Obesity
| Article | Year |
|---|---|
Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
Topics: Adipocytes; Adipose Tissue, White; Amine Oxidase (Copper-Containing); Animals; Blood Glucose; Eating | 2007 |
Hypothalamic monoamine metabolism in mice: evaluation of drug challenges and neurotoxic insult.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Animals, Newborn; Dopamine; Female; G | 1986 |
Transport and storage of 5-hydroxytryptamine in pancreatic -cells.
Topics: Animals; Biological Transport; Carbon Isotopes; Chromatography, Gel; Diazoxide; Glucose; Glyburide; | 1972 |